Stella-Jones Announces First Quarter Results

4 hours ago

2023-2025 financial objectives remain unchangedSales of $773 million, relatively unchanged from Q1 2024Operating income of $143 million, including insurance settlement…

Fortis Inc. Releases First Quarter 2025 Results

4 hours ago

This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis'…

LifeStance Reports First Quarter 2025 Results

4 hours ago

SCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers…

FAU BEPI Poll: Hispanic Economic Outlook Sinks Ahead of Tariffs, Rising Prices

4 hours ago

BOCA RATON, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- As households face increasing prices for goods and talk of new…

Radware Reports First Quarter 2025 Financial Results

4 hours ago

First Quarter 2025 Financial Results and Highlights Revenue of $72.1 million, an increase of 11% year-over-yearCloud ARR of $80 million,…

Stella-Jones Grows Into Electrical Transmission Steel Structures With the Acquisition of Locweld

4 hours ago

Company delivering on its strategy to expand infrastructure offeringMONTREAL, May 07, 2025 (GLOBE NEWSWIRE) -- Stella-Jones Inc. (TSX: SJ) (“Stella-Jones”…

Axalta Releases First Quarter 2025 Results

4 hours ago

PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) (“Axalta”), a leading global coatings company, announced its…

Magnera Reports Second Quarter Results – Provides Updated Outlook

4 hours ago

Second Quarter Highlights GAAP: Net sales of $824 million, Operating income of $4 millionNon-GAAP: Adjusted EBITDA of $89 million, Post-merger…

Nokia Corporation – Managers’ transactions (Ihamuotila)

4 hours ago

Nokia CorporationManagers’ transactions7 May 2025 at 12:20 EESTNokia Corporation - Managers' transactions (Ihamuotila)Transaction notification under Article 19 of EU Market…

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

5 hours ago

REYKJAVIK, Iceland, May 07, 2025 (GLOBE NEWSWIRE) --  Alvotech (NASDAQ: ALVO) (the “Company”) a global biotech company specializing in the…

This website uses cookies.